In genetics, complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., messenger RNA (mRNA) or microRNA (miRNA)) template in a reaction catalyzed by the enzyme reverse transcriptase. cDNA is often used to clone eukaryotic genes in prokaryotes. When scientists want to express a specific protein in a cell that does not normally express that protein (i.e., heterologous expression), they will transfer the cDNA that codes for the protein to the recipient cell. In molecular biology, cDNA is also generated to analyze transcriptomic profiles in bulk tissue, single cells, or single nuclei in assays such as microarrays and RNA-seq.
Market Analysis and Insights: Global Complementary DNA Microarrays (cDNA) Market
The global Complementary DNA Microarrays (cDNA) market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Complementary DNA Microarrays (cDNA) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Complementary DNA Microarrays (cDNA) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Complementary DNA Microarrays (cDNA) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Complementary DNA Microarrays (cDNA) include Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Complementary DNA Microarrays (cDNA) market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Complementary DNA Microarrays (cDNA), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Complementary DNA Microarrays (cDNA), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Complementary DNA Microarrays (cDNA) revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Complementary DNA Microarrays (cDNA) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Complementary DNA Microarrays (cDNA) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumnia, Affymetrix, Agilent, Scienion AG, Applied Microarrays, Arrayit, Sengenics, Biometrix Technology and Savyon Diagnostics, etc.
By Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Segment by Type
Gene expression
Genotyping
Genome cytogenetics
Segment by Application
Oncology
Non-invasive pregnancy testing(NIPT)
Hypertension
diabetes
Nervous system diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Complementary DNA Microarrays (cDNA) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complementary DNA Microarrays (cDNA) companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Complementary DNA Microarrays (cDNA) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complementary DNA Microarrays (cDNA) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Gene expression
1.2.3 Genotyping
1.2.4 Genome cytogenetics
1.3 Market by Application
1.3.1 Global Complementary DNA Microarrays (cDNA) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Non-invasive pregnancy testing(NIPT)
1.3.4 Hypertension
1.3.5 diabetes
1.3.6 Nervous system diseases
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complementary DNA Microarrays (cDNA) Market Perspective (2018-2029)
2.2 Global Complementary DNA Microarrays (cDNA) Growth Trends by Region
2.2.1 Complementary DNA Microarrays (cDNA) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Complementary DNA Microarrays (cDNA) Historic Market Size by Region (2018-2023)
2.2.3 Complementary DNA Microarrays (cDNA) Forecasted Market Size by Region (2024-2029)
2.3 Complementary DNA Microarrays (cDNA) Market Dynamics
2.3.1 Complementary DNA Microarrays (cDNA) Industry Trends
2.3.2 Complementary DNA Microarrays (cDNA) Market Drivers
2.3.3 Complementary DNA Microarrays (cDNA) Market Challenges
2.3.4 Complementary DNA Microarrays (cDNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Complementary DNA Microarrays (cDNA) by Players
3.1.1 Global Complementary DNA Microarrays (cDNA) Revenue by Players (2018-2023)
3.1.2 Global Complementary DNA Microarrays (cDNA) Revenue Market Share by Players (2018-2023)
3.2 Global Complementary DNA Microarrays (cDNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Complementary DNA Microarrays (cDNA), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Complementary DNA Microarrays (cDNA) Market Concentration Ratio
3.4.1 Global Complementary DNA Microarrays (cDNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complementary DNA Microarrays (cDNA) Revenue in 2022
3.5 Global Key Players of Complementary DNA Microarrays (cDNA) Head office and Area Served
3.6 Global Key Players of Complementary DNA Microarrays (cDNA), Product and Application
3.7 Global Key Players of Complementary DNA Microarrays (cDNA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Complementary DNA Microarrays (cDNA) Breakdown Data by Type
4.1 Global Complementary DNA Microarrays (cDNA) Historic Market Size by Type (2018-2023)
4.2 Global Complementary DNA Microarrays (cDNA) Forecasted Market Size by Type (2024-2029)
5 Complementary DNA Microarrays (cDNA) Breakdown Data by Application
5.1 Global Complementary DNA Microarrays (cDNA) Historic Market Size by Application (2018-2023)
5.2 Global Complementary DNA Microarrays (cDNA) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
6.2 North America Complementary DNA Microarrays (cDNA) Market Size by Type
6.2.1 North America Complementary DNA Microarrays (cDNA) Market Size by Type (2018-2023)
6.2.2 North America Complementary DNA Microarrays (cDNA) Market Size by Type (2024-2029)
6.2.3 North America Complementary DNA Microarrays (cDNA) Market Share by Type (2018-2029)
6.3 North America Complementary DNA Microarrays (cDNA) Market Size by Application
6.3.1 North America Complementary DNA Microarrays (cDNA) Market Size by Application (2018-2023)
6.3.2 North America Complementary DNA Microarrays (cDNA) Market Size by Application (2024-2029)
6.3.3 North America Complementary DNA Microarrays (cDNA) Market Share by Application (2018-2029)
6.4 North America Complementary DNA Microarrays (cDNA) Market Size by Country
6.4.1 North America Complementary DNA Microarrays (cDNA) Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2023)
6.4.3 North America Complementary DNA Microarrays (cDNA) Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
7.2 Europe Complementary DNA Microarrays (cDNA) Market Size by Type
7.2.1 Europe Complementary DNA Microarrays (cDNA) Market Size by Type (2018-2023)
7.2.2 Europe Complementary DNA Microarrays (cDNA) Market Size by Type (2024-2029)
7.2.3 Europe Complementary DNA Microarrays (cDNA) Market Share by Type (2018-2029)
7.3 Europe Complementary DNA Microarrays (cDNA) Market Size by Application
7.3.1 Europe Complementary DNA Microarrays (cDNA) Market Size by Application (2018-2023)
7.3.2 Europe Complementary DNA Microarrays (cDNA) Market Size by Application (2024-2029)
7.3.3 Europe Complementary DNA Microarrays (cDNA) Market Share by Application (2018-2029)
7.4 Europe Complementary DNA Microarrays (cDNA) Market Size by Country
7.4.1 Europe Complementary DNA Microarrays (cDNA) Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2023)
7.4.3 Europe Complementary DNA Microarrays (cDNA) Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
8.2 China Complementary DNA Microarrays (cDNA) Market Size by Type
8.2.1 China Complementary DNA Microarrays (cDNA) Market Size by Type (2018-2023)
8.2.2 China Complementary DNA Microarrays (cDNA) Market Size by Type (2024-2029)
8.2.3 China Complementary DNA Microarrays (cDNA) Market Share by Type (2018-2029)
8.3 China Complementary DNA Microarrays (cDNA) Market Size by Application
8.3.1 China Complementary DNA Microarrays (cDNA) Market Size by Application (2018-2023)
8.3.2 China Complementary DNA Microarrays (cDNA) Market Size by Application (2024-2029)
8.3.3 China Complementary DNA Microarrays (cDNA) Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
9.2 Asia Complementary DNA Microarrays (cDNA) Market Size by Type
9.2.1 Asia Complementary DNA Microarrays (cDNA) Market Size by Type (2018-2023)
9.2.2 Asia Complementary DNA Microarrays (cDNA) Market Size by Type (2024-2029)
9.2.3 Asia Complementary DNA Microarrays (cDNA) Market Share by Type (2018-2029)
9.3 Asia Complementary DNA Microarrays (cDNA) Market Size by Application
9.3.1 Asia Complementary DNA Microarrays (cDNA) Market Size by Application (2018-2023)
9.3.2 Asia Complementary DNA Microarrays (cDNA) Market Size by Application (2024-2029)
9.3.3 Asia Complementary DNA Microarrays (cDNA) Market Share by Application (2018-2029)
9.4 Asia Complementary DNA Microarrays (cDNA) Market Size by Region
9.4.1 Asia Complementary DNA Microarrays (cDNA) Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Complementary DNA Microarrays (cDNA) Market Size by Region (2018-2023)
9.4.3 Asia Complementary DNA Microarrays (cDNA) Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Complementary DNA Microarrays (cDNA) Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumnia
11.1.1 Illumnia Company Details
11.1.2 Illumnia Business Overview
11.1.3 Illumnia Complementary DNA Microarrays (cDNA) Introduction
11.1.4 Illumnia Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.1.5 Illumnia Recent Developments
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Complementary DNA Microarrays (cDNA) Introduction
11.2.4 Affymetrix Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.2.5 Affymetrix Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Complementary DNA Microarrays (cDNA) Introduction
11.3.4 Agilent Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.3.5 Agilent Recent Developments
11.4 Scienion AG
11.4.1 Scienion AG Company Details
11.4.2 Scienion AG Business Overview
11.4.3 Scienion AG Complementary DNA Microarrays (cDNA) Introduction
11.4.4 Scienion AG Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.4.5 Scienion AG Recent Developments
11.5 Applied Microarrays
11.5.1 Applied Microarrays Company Details
11.5.2 Applied Microarrays Business Overview
11.5.3 Applied Microarrays Complementary DNA Microarrays (cDNA) Introduction
11.5.4 Applied Microarrays Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.5.5 Applied Microarrays Recent Developments
11.6 Arrayit
11.6.1 Arrayit Company Details
11.6.2 Arrayit Business Overview
11.6.3 Arrayit Complementary DNA Microarrays (cDNA) Introduction
11.6.4 Arrayit Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.6.5 Arrayit Recent Developments
11.7 Sengenics
11.7.1 Sengenics Company Details
11.7.2 Sengenics Business Overview
11.7.3 Sengenics Complementary DNA Microarrays (cDNA) Introduction
11.7.4 Sengenics Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.7.5 Sengenics Recent Developments
11.8 Biometrix Technology
11.8.1 Biometrix Technology Company Details
11.8.2 Biometrix Technology Business Overview
11.8.3 Biometrix Technology Complementary DNA Microarrays (cDNA) Introduction
11.8.4 Biometrix Technology Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.8.5 Biometrix Technology Recent Developments
11.9 Savyon Diagnostics
11.9.1 Savyon Diagnostics Company Details
11.9.2 Savyon Diagnostics Business Overview
11.9.3 Savyon Diagnostics Complementary DNA Microarrays (cDNA) Introduction
11.9.4 Savyon Diagnostics Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.9.5 Savyon Diagnostics Recent Developments
11.10 WaferGen
11.10.1 WaferGen Company Details
11.10.2 WaferGen Business Overview
11.10.3 WaferGen Complementary DNA Microarrays (cDNA) Introduction
11.10.4 WaferGen Revenue in Complementary DNA Microarrays (cDNA) Business (2018-2023)
11.10.5 WaferGen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
听
听
*If Applicable.
